Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-22

Clinical Trial Update: Study of Sulfasalazine in Treating Painful Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of sulfasalazine for painful neuropathy; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Painful Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2018-08-22